Portfolio
4
companies
Béa Fertility
Béa Fertility provides clinical-grade fertility treatments for home use.
Fertifa
Fertifa provides reproductive healthcare wellbeing support and navigational advice to corporate clients.
The Lowdown
A digital health platform providing contraception reviews, expert consultations, and community support for women.
Thymia
Thymia builds video game-inspired tools to assess and track depression objectively.
The funding round was led by Octopus Ventures with backing from JamJar and Forward Partners.
"This latest injection of funding – from experienced investors with a proven track record of backing successful fertility and femtech businesses – will enable us to get our pioneering treatment in the hands of the people who need it most. We can’t wait for people to try it."
The seed round was led by Notion Capital and Triple Point Ventures to support team growth and clinical service expansion.
"Although there is 8x more spent on assisted reproductive technology (ART, including IVF, IUI, ICSI, etc) in Europe over the US, there are three unicorn companies in the US and none in Europe. It’s clear that there is a massive opportunity for a team with commitment to better outcomes to make a significant impact. We believe we have found this in Fertifa and are excited to see what can be achieved."
The seed round was co-led by Speedinvest and Nina Capital to fund international expansion and team growth.
"The time to invest in Women’s reproductive health is now. Alice’s ability to build community, content, and tools that women love but have never had access to is second- to-none. Contraception is just the start of The Lowdown’s bold vision in Women’s health and we are thrilled to be supporting them on it!"
The pre-seed round was co-led by Kodori AG and Calm/Storm to support product expansion and team growth.
"Thymia was born when a close friend of mine tried to take her own life. Her friends and doctors missed the signs that she was so seriously unwell, not least because the process of accessing the right treatment was based on out-dated methodologies not fit for the complexities and nuances of an illness like depression."
Calm/Storm VC led the pre-seed round, which also saw participation from QVentures and an innovation grant from InnovateUK.
"Our mission at Béa is to democratise access to effective fertility treatments; providing people with more options. ICI is clinically proven to be highly effective when it comes to increasing the chances of conception, but it’s not made available to people at the beginning of their fertility journey. Instead, they have to take a big leap into the expensive world of invasive treatments. But for people where there’s no medically-identified issue causing infertility, ICI can be the ideal way of maximising their chances of getting pregnant. We’re designing a product that enables people to do this easily and affordably, all from home."
